EGRX
Eagle Pharmaceuticals Inc
Price:  
6.29 
USD
Volume:  
128,500.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX Relative Valuation

397.7%
Upside

As of 2024-03-05, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 31.31 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.29 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 397.7%.

The range of the Relative Valuation is 19.58 - 43.46 USD.

Range Selected
Trailing P/E multiples 21.0x - 27.7x 24.6x
Forward P/E multiples 18.9x - 22.6x 20.6x
Fair Price 19.58 - 43.46 31.31
Upside 211.3% - 591.0% 397.7%
6.29 USD
Stock Price
31.31 USD
Fair Price

EGRX Relative Valuation - Historical P/E Data

Date P/E
2024-03-04 6.75
2024-03-01 6.96
2024-02-29 6.29
2024-02-28 6.73
2024-02-27 6.91
2024-02-26 6.96
2024-02-23 6.71
2024-02-22 6.30
2024-02-21 6.69
2024-02-20 6.43
2024-02-16 6.41
2024-02-15 6.28
2024-02-14 5.64
2024-02-13 5.59
2024-02-12 6.01
2024-02-09 5.71
2024-02-08 5.71
2024-02-07 5.54
2024-02-06 5.26
2024-02-05 6.01
2024-02-02 6.28
2024-02-01 6.53
2024-01-31 6.29
2024-01-30 5.88
2024-01-29 5.92
2024-01-26 5.81
2024-01-25 5.69
2024-01-24 5.30
2024-01-23 5.08
2024-01-22 4.75
2024-01-19 4.81
2024-01-18 4.86
2024-01-17 4.68
2024-01-16 4.57
2024-01-12 4.86
2024-01-11 4.83
2024-01-10 5.13
2024-01-09 5.20
2024-01-08 5.27
2024-01-05 5.51
2024-01-04 5.61
2024-01-03 5.61
2024-01-02 6.08
2023-12-29 5.61
2023-12-28 5.81
2023-12-27 5.57
2023-12-26 5.61
2023-12-22 5.32
2023-12-21 5.38
2023-12-20 5.15